'''Ipsapirone''' is a [[binding selectivity|selective]] [[5-HT1A receptor|5-HT<sub>1A</sub> receptor]] [[partial agonist]] of the [[piperazine]] and [[azapirone]] [[chemical class]]es.<ref name="pmid1981264">{{cite journal |vauthors=Fanelli RJ, Schuurman T, Glaser T, Traber J |title=Ipsapirone: a novel anxiolytic and selective 5-HT1A receptor ligand |journal=Progress in clinical and biological research |volume=361 |issue= |pages=461â€“7 |year=1990 |pmid=1981264 |doi= |url=}}</ref> It has [[antidepressant]] and [[anxiolytic]] effects.<ref name="pmid1981264" />  Ipsapirone was studied in several placebo-controlled trials for depression and continues to be used in research.<ref>{{Cite journal|url = |title = Azapirones for generalized anxiety disorder.|date = Jul 19, 2006|journal = Cochrane Database Syst Rev.|doi = 10.1002/14651858.CD006115|pmid = 16856115|access-date = |issue=3 |pages=CD006115}}</ref>
